InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Goldsmith Bruce A, Chairman & CEO. Insider active across 1 company, notably Passage BIO, Inc.. In total, 3 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €71k. Activity tracked since 21 May 2021. The latest transaction was disclosed on 21 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
10,000 shares@ US$3.150.17% mcap39.9% of flowCommon StockSEC:0001209191-22-020791:0
Ideal exit: 16 Dec 2022 (T+270)
2,000 shares@ US$13.11530.0% of flowCommon StockSEC:0001209191-21-035051
Ideal exit: 15 Feb 2022 (T+270)
2,000 shares@ US$13.1150.13% mcap30.0% of flowCommon StockSEC:0001209191-21-035051:0
Ideal exit: 15 Feb 2022 (T+270)
3 of 3 declarations
About Goldsmith Bruce A
Bruce A. Goldsmith is the Chairman & CEO at Passage BIO, Inc. In this role, he is responsible for the strategic direction of the company and the management of daily operations. Bruce plays a key role in business development and optimizing the company's performance.
